article thumbnail

Incoming ASTRO head plans to build on present leader’s momentum

Radiology Business

The American Society for Radiation Oncology has found its next CEO.

article thumbnail

What has radiology learned in 5 years since COVID hit U.S.?

AuntMinnie

While services for breast and lung cancer screening were temporarily halted, imagers in x-ray, lung ultrasound, and PET/CT were busy examining patients who presented with COVID-19. They determined standards of care between optimal, contingency, and crisis levels to figure out which cancer patients needed immediate radiation oncology care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Radiation Oncology Leaders Awarded ASTRO Fellow Designation

Imaging Technology

milla1cf Thu, 07/20/2023 - 20:09 July 20, 2023 — The American Society for Radiation Oncology ( ASTRO ) selected 29 distinguished members to receive the ASTRO Fellow ( FASTRO ) designation for its 2023 class of Fellows. A committee reviews all nominations and presents the candidates to ASTRO’s Board of Directors for approval.

article thumbnail

ASTRO: IMRT and proton therapy equally effective for prostate cancer

AuntMinnie

Intensity-modulated radiation therapy (IMRT) and proton therapy offer equally high quality of life and tumor control for people with prostate cancer, according to a study presented September 30 at the American Society for Radiation Oncology (ASTRO) annual meeting.

article thumbnail

The rise of theranostics: Part 5 -- Advice from center administrators

AuntMinnie

Beyder, along with Vikas Prasad, MD, PhD, and BJH/WU Radiation Oncology all played an integral role in launching the SNMMI radiopharmaceutical therapy (RPT) comprehensive center of excellence at WU, Barnes-Jewish Hospital, and Siteman Cancer Center last year.

article thumbnail

IMV: PET scan volumes continue to grow

AuntMinnie

In 2023, 38% of PET systems were operated by the PET department, 28% by nuclear medicine, 24% by radiology/imaging, 5% by radiation oncology, and 2% by molecular imaging. For information about purchasing IMV Market Outlook Reports, visit the corporate website at [link] or call 703-778-3080 ext. 1033 to speak with a representative.

PET Scan 290
article thumbnail

Multi-Institutional Study Data Presented at ASTRO 2023 Builds Upon Growing Evidence of GammaTile for Patients with Brain Tumors

Imaging Technology

The findings add to the growing evidence of the efficacy and safety of its FDA-approved GammaTile Therapy, and were presented during an Oct. 2 poster presentation at the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, ASTRO 2023 , being held this week in San Diego, CA.